Skip to main content
Clinical, Cosmetic and Investigational Dermatology logoLink to Clinical, Cosmetic and Investigational Dermatology
. 2022 Jan 12;15:43–50. doi: 10.2147/CCID.S343274

Clinical and Pathological Characteristics of 755 Patients with Skin Cancers in Hainan, China: A 12-Year Retrospective Study

Lengbing Sun 1,2,*, Jiejie Lu 1,*, Ming Zhang 1, Xianxu Yang 1, Weiwei Wu 1,, Qiao Liu 2,3,
PMCID: PMC8763201  PMID: 35046688

Abstract

Background

Skin cancers are the most frequent types of all malignant tumours with increasing incidence rates. The incidence rate varies between different countries around the world.

Objective

This study aimed to analyze the clinical–pathological characteristics of skin cancers in patients visited at the Department of Dermatology of the Fifth People’s Hospital of Hainan Province from China during the last 12 years.

Methods

The hospital database was searched for patients with skin cancers over a period of 12 years (from January 1, 2009 to December 31, 2020), and a retrospective review was conducted and a descriptive data analysis was undertaken on patients.

Results

A total of 755 specimens of skin cancers were confirmed during this period. The common skin cancers were basal cell carcinoma (341, 48.99%), followed by squamous cell carcinoma (148, 21.26%) and Bowen’s disease (109, 15.66%). The range of age at the time of skin cancers onset was mainly from 40 to 79 years (73.01%). The disease duration ranged from 7 days to 70 years, mainly occurred in 2 years (53.30%). The lesions were most frequently located in the region of head, face and neck (452, 59.87%), followed by extremity (107, 14.17%) and trunk (87, 11.52%). The accordance rate of clinical-pathological diagnosis in common skin cancers was about 43.14%, while that of rare skin cancers was only 27.59%.

Conclusion

Overall, head, face and neck region was the most common sites for sun-related skin cancers in Hainan, China. The coincidence rate of initial diagnosis and pathological diagnosis was low in skin cancers. Consequently, any suspicious lesion, for which the clinical diagnosis is uncertain, should be biopsied for histopathological examination to rule out malignancy.

Keywords: skin cancers, retrospective study, Hainan, China

Introduction

Skin cancers showed increasing incidences around the world.1 The most common types of skin cancers, comprising of skin melanoma and non-melanoma skin cancers (NMSCs), account for more than one-third of all cancers.2 NMSCs are the most frequent human malignancies, and the main types of that, basal cell carcinoma (BCC) and squamous cell carcinoma (SCC), represent about 99% of all NMSCs.2,3 Other NMSCs refer to Merkel cell carcinoma, dermatofibrosarcoma protuberans, Kaposi sarcoma and other rare tumours.4 The incidence of malignant melanoma (MM) has shown a continuous increase, during the past few decades, which accounts for 80% of skin cancer deaths.5

The majority of skin cancers published in the literature are white-skinned populations with few references reported to date in the literature on Asians, especially in China. Hainan, as the southernmost province in China, has a tropical monsoon climate and high ultraviolet (UV) intensity, so the occurrence of skin cancers may has its particularity. However, similar comparative studies are lacking. Therefore, the first population-based data of skin cancers in patients visited at the Department of Dermatology of the Fifth People’s Hospital of Hainan Province are presented in this paper and compared with other regions in China. Further results on clinical–pathological characteristics are discussed in the context of global data.

Materials and Methods

A retrospective and descriptive analysis of the patients with definite histopathologic diagnosis of skin cancers, based on the histopathologic analysis of all excision specimens and incisional biopsy specimens performed between 1 January 2009 and 31 December 2020 at the Department of Dermatology, the Fifth People’s Hospital of Hainan Province, Hainan, China. Complete clinical and pathological data were collected and reviewed.

Biopsies showing recurrence or persistence of previously diagnosed neoplasms were excluded. The suspected diagnosis and incomplete clinical-pathological data were not collected.

Skin cancers in the present study were considered, as follows: BCC, SCC, Bowen’s disease, Paget’s disease, MM, Kaposi’s sarcoma (KS), cutaneous lymphomas, cutaneous metastatic carcinoma, dermatofibrosarcoma, angiosarcoma, mycosis fungoides, verrucous carcinoma, hematological malignancies, eccrine carcinoma, Langerhans cell histiocytosis, sebaceous carcinomas, leiomyosarcoma, breast ductal carcinoma.

The data were compiled and analyzed for various data such as gender, age of onset and of diagnosis, disease duration, distribution of lesions, clinical and histopathologic diagnosis.

Results

A total of 755 specimens of skin cancers were confirmed during this period, of which 696 were common skin cancers (Table 1) and of which 59 were rare skin cancers (Table 2). 755 cases of skin cancers constituted 5.15% of 14,664 cases of excision specimens and incisional biopsy specimens in the same period. The incidence is on the rise year by year, with a marked decline in 2020, as shown in Figure 1.

Table 1.

The Clinical Characteristics of 696 Patients with Common Skin Cancers

Common Skin Cancers No. (%) Male Female Onset Age (Inline graphic, Years) Age at Diagnosis (Inline graphic, Years) Duration (Inline graphic, Months) Location
Head, Face and Neck Trunk Extremity Vulva Perianal Region Mucosa Acral Region Not Indicated Region
BCC 341(48.99) 152(44.57) 189(55.43) 59.32±17.78 65.16±14.57 73.12±115.95 311(91.20) 12(3.52) 11(3.23) 3(0.88) 0 0 1(0.29) 3(0.88)
SCC 148(21.27) 75(50.68) 73(49.32) 67.67±15.25 70.57±14.93 36.26±63.94 90(60.81) 18(12.16) 25(16.89) 9(6.08) 1(0.68) 1(0.68) 2(1.35) 2(1.35)
Bowen’s disease 109(15.66) 57(52.29) 52(47.71) 60.09±16.95 64.91±15.21 67.54±94.50 38(34.86) 24(22.02) 11(10.09) 26(23.85) 2(1.84) 0 7(6.42) 1(0.92)
Paget’s disease 47(6.75) 32(68.09) 15(31.91) 64.28±13.77 67.66±12.43 42.33±46.04 1(2.13) 11(23.40) 0 34(72.34) 1(2.13) 0 0 0
MM 28(4.02) 14(50.00) 14(50.00) 58.70±16.12 60.50±15.53 36.00±39.80 1(3.57) 1(3.57) 17(60.72) 1(3.57) 0 0 7(25.00) 1(3.57)
KS 23(3.31) 20(86.96) 3(13.04) 63.20±17.39 65.17±14.74 44.25±90.85 0 2(8.69) 20(86.96) 1(4.35) 0 0 0 0
Total 696(100) 350(50.29) 346(49.71) 61.65±17.16 66.26±14.88 60.06±98.20 441(63.36) 68(9.77) 84(12.07) 74(10.63) 4(0.58) 1(0.14) 17(2.44) 7(1.01)

Table 2.

The Clinical Characteristics of 59 Patients with Rare Skin Cancers

Rare Skin Cancers No. (%) Male Female Onset Age (Inline graphic, Years) Age at Diagnosis (Inline graphic, Years) Duration (Inline graphic, Months) Location
Head, Face and Neck Trunk Extremity Vulva Perianal Region Mucosa Acral Region Not Indicated Region
Cutaneous lymphomas 14 6 8 11–91 12–91 0.5–60 1 4 9 0 0 0 0 0
Cutaneous metastatic carcinoma 10 4 6 50–89 50–89 2–24 0 5 4 1 0 0 0 0
Dermatofibrosarcoma 8 5 3 10–63 10–73 0.5–180 0 4 3 0 0 0 1 0
Angiosarcoma 7 6 1 56–89 56–90 2–12 6 1 0 0 0 0 0 0
Mycosis fungoides 5 3 2 35–70 51–70 1–240 0 2 3 0 0 0 0 0
Verrucous carcinoma 4 3 1 35–70 35–71 4–96 0 0 2 1 0 0 1 0
Hematological malignancies 3 2 1 14–82 14–83 4–120 2 0 1 0 0 0 0 0
Eccrine carcinoma 3 2 1 41–58 47–61 6–96 2 0 1 0 0 0 0 0
Langerhans cell histiocytosis 2 1 1 0.08–0.42 0.33–0.66 3 0 2 0 0 0 0 0 0
Sebaceous carcinomas 1 0 1 41 41 6 0 0 0 0 0 0 1 0
Leiomyosarcoma 1 0 1 48 50 24 0 0 0 1 0 0 0 0
Breast ductal carcinoma 1 1 0 36 38 24 0 1 0 0 0 0 0 0
Total 59 33 26 11 19 23 3 0 0 3 0

Figure 1.

Figure 1

Trend of skin cancers between 2009 and 2020.

There were 383 males (50.73%) and 372 females (49.27%) with skin cancers, no significant difference in gender was observed (Table 3). The range of age at the time of skin cancers onset was from 1 month to 96 years, of which most of them were between 40 and 79 years, with an incidence of 73.01% (Table 4, Figure 2). The disease duration ranged from 7 days to 70 years, mainly occurred in 2 years (Table 5, Figure 3).

Table 3.

Distribution of Gender and Location of Skin Cancers

Skin Cancers No. (%) Male Female Location
Head, Face and Neck Trunk Extremity Vulva Perianal Region Mucosa Acral Region Not Indicated Region
BCC 341 152 189 311 12 11 3 0 0 1 3
SCC 148 75 73 90 18 25 9 1 1 2 2
Bowen’s disease 109 57 52 38 24 11 26 2 0 7 1
Paget’s disease 47 32 15 1 11 0 34 1 0 0 0
MM 28 14 14 1 1 17 1 0 0 7 1
KS 23 20 3 0 2 20 1 0 0 0 0
Rare skin cancers 59 33 26 11 19 23 3 0 0 3 0
Total 755(100) 383(50.73) 372(49.27) 452(59.87) 87(11.52) 107(14.17) 77(10.20) 4(0.53) 1(0.13) 20(2.65) 7(0.93)

Table 4.

Age Distribution of Skin Cancers

Skin Cancers Onset Age (Years)
0–19 20–39 40–59 60–79 80–99
BCC 10 33 110 136 38
SCC 1 7 32 62 37
Bowen’s disease 2 9 38 41 11
Paget’s disease 0 2 13 25 6
MM 0 3 10 7 3
KS 1 0 5 10 4
Rare skin cancers 6 11 20 13 9
Total 20(2.8) 65(9.09) 228(31.89) 294(41.12) 108(15.1)

Figure 2.

Figure 2

Age distribution of skin cancers.

Table 5.

Analysis of the Duration of Skin Cancers

Skin Cancers Duration (Months)
0–24 25–48 49–72 73–96 ≥96
BCC 142 64 31 9 78
SCC 98 15 11 1 14
Bowen’s disease 39 22 14 5 22
Paget’s disease 24 9 6 1 6
MM 13 6 2 0 3
KS 17 0 0 0 3
Rare skin cancers 47 0 4 0 7
Total 380(53.30) 116(16.27) 68(9.54) 16(2.24) 133 (18.65)

Figure 3.

Figure 3

Analysis of the duration of skin cancers.

The most frequent location was head, face and neck region (452, 59.87%), followed by trunk (87, 11.52%), extremity (107, 14.17%), vulva (77, 10.20%), perianal region (4, 0.53%), mucosa (1, 0.13%), acral region (20, 2.65%) and not indicated region (7, 0.93%). Overall, head, face and neck region was the most common site for BCC (91.20%), SCC (60.81%) and Bowen’s disease (34.86%); Paget’s disease was most frequently found on vulva and extremity, while Kaposi’s sarcoma was most frequently found on the extremity (86.96%), as shown in Table 3.

755 cases of skin cancers has a low coincidence rate of clinical-pathological diagnosis, as shown in Table 6. The coincidence rate was defined as the concordant ratio between clinical diagnosis and pathological diagnosis. The coincidence of clinical-pathological diagnosis ranged from 25.00% to 63.83%, which indicated a difficulty in clinical diagnosis.

Table 6.

The Coincidence of Clinical-Pathological Diagnosis in 755 Cases of Skin Cancers

Skin Cancers No. The Coincidence of Clinical-Pathological Diagnosis (%) Misdiagnosed Diseases (Cases)
BCC 341 53.37 Pigmented nevi (47), MM(24), SCC(17), seborrheic keratosis(10), Bowen’s disease(9), skin ulcer(5), keratoacanthoma(5), cutaneous granuloma(5), deep mycosis(3), other diseases(18)
SCC 148 25.00 SCC(36), BCC(32), seborrheic keratosis(12), keratoacanthoma(10), cutaneous granuloma(6), verruca vulgaris(5), Bowen’s disease(5), deep mycosis(4), skin ulcer(4), condylomata acuminata(3), solar keratosis(3), cutaneous horn(3), eczema(3), epidermal cyst(3), other diseases(22)
Bowen’s disease 109 27.52 BCC(17), seborrheic keratosis(13), eczema(9), SCC(5), condylomata acuminata(3), Paget’s disease(3), other diseases(22)
Paget’s disease 47 63.83 eczema (10), SCC(3), other diseases(3)
MM 28 50.00 BCC(3), SCC(2), pigmented nevi(2), cutaneous granuloma(2), lichen planus(1), melanoma(1), onychomycosis(1), deep mycosis(1), keratoacanthoma(1)
KS 23 39.13 MM(2), eczema(2), pigmented nevi(1), skin tuberculosis(1), hemangioma(1), deep mycosis(1), keratoacanthoma(1), dermatofibroma(1)
Rare skin cancers 59 27.59 BCC(4), SCC(4), sebaceous cyst(3), other diseases(35)

Discussion

Eighteen types of skin cancers were observed in the present study. These were BCC (48.99%), SCC (21.26%), Bowen’s disease (15.66%), Paget’s disease (6.75%), MM (4.02%), KS (3.30%) in common skin cancers and twelve types were in rare skin cancers.

The percentage of common skin cancers was compared with similar reports from other areas of China. The top three skin cancers of different areas were similar, including Tianjin (North of China; BCC, 50.97%, Bowen’s disease, 16.01% and SCC, 11.06%),6 Chongqing (Southwest of China; BCC, 34.06%, SCC, 17.63% and Bowen’s disease, 10.20%),7 Xinjiang (Northwest of China; BCC, 47.00%, SCC, 26.22% and KS, 15.17%),8 Qinghai (Northwest of China; BCC, 47.00%, SCC, 26.22% and KS, 15.17%).9 BCC, SCC, Bowen’s disease and KS were the most common skin cancers in China. This can be attributed to prolonged exposure to sun rays, environment, altitude and so on.9

In both sexes, males and females observed an almost similar incidence.8–10 In our study, BCC was slightly more common in females than in males; Paget’s disease and KS were more common in males; SCC, MM and Bowen’s disease showed an almost similar incidence in gender. Interestingly, Katalinic et al2 found a female predominance in melanoma, while some clear gender differences were not observed in nonmelanoma.

Although skin cancers may present at a very young age,11 it is essentially senile disease in elderly people,12 which is consistent with the results of our study. In our study, the most common age group ranged between 40 and 79 years. Furthermore, the disease duration mainly occurred in 2 years, which suggested that most of these tumors progress rapidly. Therefore, we should pay attention to the occurrence of skin cancers in young and middle-aged patients.

The most common site of skin cancers were located on the head, face and neck region (59.87%), of which BCC was 91.20% and SCC was 60.81%. It is suggested that UV plays an important role in the pathogenesis of BCC and SCC. This may be related to prolonged exposure to sun rays. Our results was in accordance with prior studies of similar latitudes such as Norwegian.13 Skin cancers are rare in rarely UV-exposed areas such as the buttocks in both sexes. In addition, Paget’s disease is more common in genital parts, and it is easy to be misdiagnosed as eczema in male.

Our findings has indicated a higher incidence of misdiagnosis clinically. The coincidence rate of clinical and pathological diagnosis of Paget’s disease is only 63.83%, followed by BCC 53.37%, MM 50.00%, KS 39.13%, other rare skin cancers 27.59%, Bowen’s disease 27.52%, and SCC 25.00%. Hence, it is of great significance to master the characteristics of skin cancers and the accurate diagnosis should be confirmed by pathological diagnosis.

In conclusion, BCC, SCC and Bowen’s disease are the most common skin cancers in Hainan Province, with head, face and neck region being the most common site involved. Moreover, skin cancers has a low coincidence rate of clinical-pathological diagnosis. Consequently, any suspicious lesion, for which the clinical diagnosis is uncertain, should be biopsied for histopathological examination to rule out malignancy.

Funding Statement

This work was supported by the Construction Project of Hainan Province Clinical Medical Center.

Ethics Approval and Consent to Participate

This study was conducted with approval from the Ethics Committee of the Fifth People’s Hospital of Hainan Province. This study was conducted in accordance with the declaration of Helsinki. Written informed consent was obtained from the patients prior to study commencement.

Author Contributions

All authors made a significant contribution to the work reported, whether that is in the conception, study design, execution, acquisition of data, analysis and interpretation, or in all these areas; took part in drafting, revising or critically reviewing the article; gave final approval of the version to be published; have agreed on the journal to which the article has been submitted; and agree to be accountable for all aspects of the work.

Disclosure

The authors declare no conflicts of interest.

References

  • 1.Leiter U, Keim U, Garbe C. Epidemiology of skin cancer: update 2019. Adv Exp Med Biol. 2020;1268:1268123–1268139. [DOI] [PubMed] [Google Scholar]
  • 2.Katalinic A, Kunze U, Schäfer T. Epidemiology of cutaneous melanoma and non-melanoma skin cancer in Schleswig-Holstein, Germany: incidence, clinical subtypes, tumour stages and localization (epidemiology of skin cancer). Br J Dermatol. 2003;149(6):1200–1206. doi: 10.1111/j.1365-2133.2003.05554.x [DOI] [PubMed] [Google Scholar]
  • 3.Ciążyńska M, Kamińska-Winciorek G, Lange D, et al. The incidence and clinical analysis of non-melanoma skin cancer. Sci Rep. 2021;11(1):4337. doi: 10.1038/s41598-021-83502-8 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Losquadro W-D. Anatomy of the skin and the pathogenesis of nonmelanoma skin cancer. Facial Plast Surg Clin North Am. 2017;25(3):283–289. doi: 10.1016/j.fsc.2017.03.001 [DOI] [PubMed] [Google Scholar]
  • 5.Ortiz-álvarez J, Durán-Romero A-J, Hernández-Rodríguez J-C, et al. Cutaneous malignant melanoma mortality in Andalusia from 1979 to 2018. Toward new perspectives?. Dermatol Ther. 2021;34(1):e14715. [DOI] [PubMed] [Google Scholar]
  • 6.Haixia G, Gang L, Feng L, et al. Retrospective analysis of 1 293 patients with skin cancer. Chin J Dermatovenereol Integr Traditional Western Med. 2019;18(02):107–110. [Google Scholar]
  • 7. Ya X, Heng Y, Yan L, et al. Retrospective analysis of 1 333 cases with skin malignant tumor. J Pract Dermatol. 2013;6(02):77–79. [Google Scholar]
  • 8.Xuefeng W, Lijuan Z, Junwei F, et al. Retrospective analysis of 574 patients with skin cancer. Chin J Dermatovenereol. 2017;31(09):972–974. [Google Scholar]
  • 9.Yuxiang L, Qiang F, Xiuchun Z, et al. Clinical analysis of 122 cases with skin malignant tumor in Qinghai. Chin J Dermatovenereol. 2016;30(03):254–256. [Google Scholar]
  • 10.Yuanshen H, Hang L, Ping T, et al. Skin cancer and precancerous skin lesions: clinical analysis of 632 cases. Chin J Dermatol. 2010;07:452–454. [Google Scholar]
  • 11.Eggen CAM, Durgaram VVL, van Doorn R, et al. Incidence and relative survival of melanoma in children and adolescents in the Netherlands, 1989–2013. JEADV. 2018;32(6):956–961. doi: 10.1111/jdv.14665 [DOI] [PubMed] [Google Scholar]
  • 12.Rajbhar R, Anvikar A, Sulhyan K. Clinicopathological correlation of malignant skin tumors: a retrospective study of 5 years. Int J Health Sci. 2020;14(3):18–25. [PMC free article] [PubMed] [Google Scholar]
  • 13.Liu F-C, Grimsrud T-K, Veierød M-B, et al. Ultraviolet radiation and risk of cutaneous melanoma and squamous cell carcinoma in males and females in the Norwegian Offshore Petroleum Workers cohort. Am J Ind Med. 2021;64(6):496–510. doi: 10.1002/ajim.23240 [DOI] [PubMed] [Google Scholar]

Articles from Clinical, Cosmetic and Investigational Dermatology are provided here courtesy of Dove Press

RESOURCES